What's New on the FDA Drugs Site
June 30, 2017
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA Issues Draft Guidance: Product Identifier Requirements Under the Drug Supply Chain Security Act – Compliance Policy
- Key Provisions of the Drug Supply Chain Security Act
- Drug Supply Chain Security Act Webinars and Presentations
- Drug Supply Chain Security Act Public Meetings
- Are you ready for the Drug Supply Chain Security Act?
- National Drug Code Directory
- Product Identifier Requirements Under the Drug Supply Chain Security Act – Compliance Policy Guidance for Industry (PDF - 101KB)
- Spotlight on CDER Science: Lab Tests in Rodents Suggest Potential New Biomarker for Acute Pancreatic Injury
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
- CDER Rare Diseases Public Workshop: Strategies, Tools and Best Practices for Effective Advocacy in Rare Diseases Drug Development
- Developing Rabies Monoclonal Antibody Products as a Component of Rabies Post-exposure Prophylaxis(updated)
- Development of New Tuberculosis Drug Regimens-Scientific and Clinical Design Considerations(updated)
No hay comentarios:
Publicar un comentario